Female Genital Cancer Screenings

Female Genital Cancer Screenings: Early Diagnosis and Preventive Approaches

When it comes to female genital cancers, our most powerful weapon is regular screening performed before the disease shows any symptoms. Early diagnosis is often synonymous with a “complete cure.” By using modern screening protocols and advanced technological diagnostic methods, Prof. Dr. Selçuk Erkılınç detects and treats processes carrying a risk of cancer at their very initial stage.

Cervical Cancer Screening: Smear and HPV Tests

Cervical cancer is the area where the most successful results are obtained among screenable cancers. The main purpose of screening programs is to catch precancerous lesions (premalignant structures).

• Pap-Smear Test: This is the microscopic examination of shed cells collected from the cervix. It allows us to view structural changes in the cells at an early stage.

• HPV DNA Test: It investigates the presence of high-risk HPV types (particularly Types 16 and 18) that lead to cancer. Today, the “Co-test” application performed together with a Smear offers the most reliable results.

• Colposcopy Application: In patients with detected abnormalities in their test results, Prof. Dr. Selçuk Erkılınç examines the cervix in detail using a specialized magnifying device (colposcope) and establishes a definitive diagnosis by taking millimetric biopsies if necessary.

Points to Consider in Ovarian and Uterine Cancer Screenings

Although there is no standard “community screening test” for ovarian and uterine cancers like there is for cervical cancer, identifying risk groups and undergoing regular check-ups carry vital importance.

• Pelvic Ultrasonography: It is used to understand the character of cysts in the ovaries and to measure the thickness of the uterine lining (endometrium). The frequency of these check-ups should be increased, especially in individuals with a family history of cancer.

• Tumor Markers (CA-125, etc.): These parameters checked in the blood are evaluated by Dr. Erkılınç to support the clinical picture, particularly in cases deemed high-risk.

• Genetic Counseling: Investigating genetic mutations such as BRCA1 and BRCA2 in individuals with a dense family history of breast or ovarian cancer ensures the creation of a personalized protective shield.

Vulvar and Vaginal Cancer Screening

These relatively rarer types of cancer are generally detected during physical examinations.

• Observation and Examination: Color changes, non-healing sores, or itchy lesions in the genital area must be evaluated by a specialist eye.

• Vulvoscopy: This is the procedure of examining suspicious areas under magnification. Dr. Erkılınç diagnoses risky tissues in these regions early on to determine the necessity of surgical intervention.

The Difference of Prof. Dr. Selçuk Erkılınç in Cancer Screenings

Cancer screening is not just about having a test done; it is about correctly interpreting these test results from an expert oncological perspective. Prof. Dr. Selçuk Erkılınç does not merely present test results to his patients; he performs risk analysis, discusses preventive surgical options when necessary, and establishes a personalized follow-up schedule suitable for every woman’s age, genetic heritage, and lifestyle.